Projects per year
Generating Evidence that RABEP2 is a Novel GSK3 Substrate that Represents a Single Therapeutic Target to Reduce Both Hyperglycemia and Microvascular Disease in Diabetes (joint with Glasgow Uni)
1/04/20 → 31/03/23
Breast Cancer Campaign: Tissue Bank Extension (Joint with University of London, University of Leeds and University of Nottingham)
Coates, P., Herrington, S., Jordan, L., Purdie, C. & Quinlan, P.